Salesforce.com startled Silicon Valley techies last month by acquiring Heroku, a San Francisco startup born just three years earlier at Y Combinator, the venture incubator program. Heroku’s specialty is hosting Web-based applications written in Ruby, a programming language so powerful yet easy to use that it has become the tool of choice for developers building … Continue reading “Engine Yard: The Ruby on Rails Company Salesforce Didn’t Buy”
$3M for Solar Power Partners
Solar Power Partners, a Mill Valley, CA-based solar electricity producer that manages large solar installations and sells the power to utilities and commercial entities, has raised $3 million in debt and securities, according to a regulatory filing. The amount was small compared to previous fundraising rounds, including a $100 million round in 2008 led by … Continue reading “$3M for Solar Power Partners”
Startups—So Easy A 12-Year-Old Can Do It
Out of the mouths babes. Maybe because it’s a company town and everyone in Silicon Valley has a family connection to entrepreneurship. Or maybe I just encountered the most entrepreneurial 12-year-olds ever assembled under one roof. Or maybe we’re now teaching entrepreneurial thinking in middle schools. Either way I had an astounding evening as one … Continue reading “Startups—So Easy A 12-Year-Old Can Do It”
Alexion Pharma Gobbles Up Taligen in $111M Buyout
There’s big news for Taligen Therapeutics this morning. Cheshire, CT-based Alexion Pharmaceuticals (NASDAQ:[[ticker:ALXN]]) has bought the Cambridge, MA, biotech startup for $111 million and potential future payments, the buyer said today. The deal allows Alexion to obtain Taligen’s lead candidate, TT30, which Taligen had been developing as a potential rival to Alexion’s drug eculizumab (Soliris) … Continue reading “Alexion Pharma Gobbles Up Taligen in $111M Buyout”
Motricity Snaps Up Adenyo For $150M
Motricity, the Bellevue, WA-based maker of mobile technology, said today it has acquired Adenyo, a mobile marketing, advertising and analytics solutions provider in the U.S., Canada and France. Motricity (NASDAQ: [[ticker:MOTR]]) has agreed to pay $100 million upfront through a combination of cash and stock, plus as much as $50 million more in cash and … Continue reading “Motricity Snaps Up Adenyo For $150M”
Qualcomm’s CEO Talks Wireless Health, InLab Ventures Pioneers New VC Model, Fallbrook Technologies Tops Deals List, & More San Diego BizTech News
If there was a theme to last week’s biztech news in San Diego, it might be learning how to negotiate the complexities of technology innovation. We’ve got it wrapped up for you, from Qualcomm’s Paul Jacobs to Sorenson Media’s Eric Quanstrom. —During a panel discussion about combating chronic disease at last week’s World Economic Forum … Continue reading “Qualcomm’s CEO Talks Wireless Health, InLab Ventures Pioneers New VC Model, Fallbrook Technologies Tops Deals List, & More San Diego BizTech News”
Genzyme Lets Sanofi Conduct Due Diligence
Cambridge, MA-based biotech Genzyme (NASDAQ: [[ticker:GENZ]]) announced that its board has authorized the company to enter into a confidentiality agreement with Sanofi-Aventis to allow the firm to conduct due diligence on Genzyme, as part of Sanofi’s pursuit to purchase the biotech company. Genzyme has previously turned down Sanofi’s $18.5 billion ($69-per-share tender offer), but today’s … Continue reading “Genzyme Lets Sanofi Conduct Due Diligence”
Molecular Insight Pharma, Xconomy’s Neighbor, Faces Uncertain Future in Chapter 11
Molecular Insight Pharmaceuticals, which shares a floor with Xconomy in the building at 101 Rogers Street, is in financial trouble. The Cambridge, MA-based company, a developer of molecular medicines for cancer founded in 1997, has been in Chapter 11 since December 9. The company, which defaulted last year on a $150 million bond, has been … Continue reading “Molecular Insight Pharma, Xconomy’s Neighbor, Faces Uncertain Future in Chapter 11”
Uptake Medical Ups and Goes to the O.C., Retains Technical Center in Seattle
One of the best-financed medical device startups in Seattle, Uptake Medical, has moved its headquarters to southern California to tap into a deeper pool for medical device industry talent, Xconomy has learned. Uptake Medical moved its headquarters to the medical device hub in Orange County last fall, CEO King Nelson says. The company has retained … Continue reading “Uptake Medical Ups and Goes to the O.C., Retains Technical Center in Seattle”
CloudTP Comes Out of Stealth, With $1M in Equity Seed Funding, to Help Big Companies Move Data to Their Own Private Clouds
Serial IT entrepreneur Chris Greendale is taking a crack at another company, which is involved in what he calls “carbon reduction by cloud computing. It’s not exactly the most commonly thought of means to sustainability, but his new firm, Boston-based CloudTP, is focused on helping firms reduce the need for their own physical data centers … Continue reading “CloudTP Comes Out of Stealth, With $1M in Equity Seed Funding, to Help Big Companies Move Data to Their Own Private Clouds”
Encouraging Women in Industry to Apply for Faculty Jobs
Over the years, I noticed that we’d hired some terrific faculty at the University of Washington who came directly from industry. These faculty members have quickly gotten up to speed, and they’ve loved their new academic careers. It occurred to me that this would be a great way to get more women faculty in science, … Continue reading “Encouraging Women in Industry to Apply for Faculty Jobs”
Uncle Sam Hearts Drugs, Not Devices. Why?
WTF! You can forgive medical device investors and CEOs if they’ve uttered that not-so-family-friendly acronym during the last year or so. First, the Food and Drug Administration signals it will likely tighten restrictions on the popular 510(k) regulatory program, which allows device makers to quickly develop new products that are slightly better or different than … Continue reading “Uncle Sam Hearts Drugs, Not Devices. Why?”
Solar Power Partners Lands $3,000,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ef3f3ffd-abf8-4bda-87c8-54ee1f685d15&Preview=1 Date 1/31/2011 Company Name Solar Power Partners Mailing Address 100 Shoreline Highway Mill Valley, CA 94941 Company Description Solar Power Partners, Inc. (SPP) is a developer, owner, and manager (DOM) of a distributed network of mid-size commercial Solar Energy Facilities (SEF) that we remotely manage from a central location. SPP provides … Continue reading “Solar Power Partners Lands $3,000,000 New Funding Round”
Project Frog Receives $6,500,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7dd0b25d-a591-46bd-bcca-7ea6d64037e1&Preview=1 Date 1/31/2011 Company Name Project Frog Mailing Address 1500 Sansome Street 2nd Floor San Francisco, CA 94111 Company Description Project FROG is a pioneering firm that integrates sustainability and customization into quick-to-deploy, high performance building environments. Our mission is to provide a transformational landscape of sustainable, friendly, and affordable learning environments … Continue reading “Project Frog Receives $6,500,000 New Financing Round”
Xilinx Acquires AutoESL Design Technologies for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e12af239-a202-4e1a-bd8e-64592da11494&Preview=1 Date 1/31/2011 Company Name AutoESL Design Technologies Mailing Address 20245 Stevens Creek Blvd. Cupertino, CA 95014 Company Description AutoESL Design Technologies (AutoESL), Inc. is a privately held hi-tech company providing platform-based communication-centric Electronic System Level (ESL) synthesis tools in the field of Electronic Design Automation (EDA) for integrated circuits and systems. … Continue reading “Xilinx Acquires AutoESL Design Technologies for Undisclosed Sum”
Floop Garners $300,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=12752850-6881-4ac2-af34-b484535f4780&Preview=1 Date 1/31/2011 Company Name Floop Mailing Address 1 Bradley Road Woodbridge, CT 06525 Company Description The company is developing a real-time interactive social network for mobile, iPad and the web that lets users express opinions and see what their friends and the World Bank. Website Undisclosed Transaction Type Debt Transaction Amount … Continue reading “Floop Garners $300,000 New Round”
Alexion Pharmaceuticals Acquires Taligen Therapeutics for $111,000,000
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c8d06b6d-cc39-459f-91f9-07857e961c4c&Preview=1 Date 1/31/2011 Company Name Taligen Therapeutics Mailing Address 12635 East Montview Blvd Aurora, CO 80045 Company Description Taligen’s lead technology is directed at inhibiting factor B, an essential component in the amplification of complement activation. Inhibition of factor B down-regulates complement activation, thereby dampening the inflammatory response. Taligen’s second technology is … Continue reading “Alexion Pharmaceuticals Acquires Taligen Therapeutics for $111,000,000”
LibreDigital Obtains $4,000,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=cee66060-34fb-4bf2-84ea-613e71d495bb&Preview=1 Date 1/31/2011 Company Name LibreDigital Mailing Address 1835-B Kramer Lane Austin, TX 78758 Company Description When LibreDigital formed in 1999 to provide publishers with digital warehousing and e-distribution, the web was a place for email, retail, and early content experiments. The term “blog” had just been coined. Social networking was the … Continue reading “LibreDigital Obtains $4,000,000 New Financing Round”
ReachForce Obtains $4,600,000 Series B Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=bd05a6b2-bfcb-4efa-9396-f933e9bc7976&Preview=1 Date 1/31/2011 Company Name ReachForce Mailing Address 9020-I Capital of Texas Hwy. N Austin, TX 78759 Company Description ReachForce is a worldwide provider of OnDemand Data Services for CRM – Driving Marketing initiatives and Sales effectiveness. ReachForce’s revolutionary approach increases demand generation effectiveness and accelerates sales cycles by delivering high quality … Continue reading “ReachForce Obtains $4,600,000 Series B Funding”
Zero Motorcycles Secures $2,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=4e034375-f88a-4d08-82b4-9e2faf0cf6d8&Preview=1 Date 1/29/2011 Company Name Zero Motorcycles Mailing Address 1 Victor Square Scotts Valley, CA 95066 Company Description Zero Motorcycles is the next step in motorcycle evolution and represents the ultimate electric motorcycle technology. Unencumbered by conventional thinking about how we design, manufacture, and sell high performance electric motorcycles, we’re on a … Continue reading “Zero Motorcycles Secures $2,000,000 New Funding”
San Diego’s Fight Against Diabesity: The Photo Gallery
Obesity and diabetes are the two biggest health scourges we’ll face over the coming decades, according to public health officials. Yet it has never seemed more daunting to develop new treatments or technologies to put a dent in the twin epidemics. We had a fascinating conversation about the dilemma of this business last night at … Continue reading “San Diego’s Fight Against Diabesity: The Photo Gallery”
How the Challenger Disaster Changed My Life
The space shuttle Challenger exploded shortly after liftoff on January 28, 1986—twenty-five years ago today. The disaster took the lives of six astronauts and one schoolteacher, and shook NASA to its core. Like other televised national traumas, it burned itself into the memories of millions of people. I was just a spectator to the catastrophe, … Continue reading “How the Challenger Disaster Changed My Life”
New Oncology R&D House H3 Biomedicine Launches in Cambridge, With Eisai Support
A new cancer treatment R&D operation is starting up in Cambridge, MA, based on the work of Broad Institute of Harvard and MIT founding members Stuart Schreiber and Todd Golub. H3 Biomedicine announced it has launched to develop treatments tailored to patients’ cancers, as part of a partnership with the U.S. unit of the Japanese … Continue reading “New Oncology R&D House H3 Biomedicine Launches in Cambridge, With Eisai Support”
Meritage Swallows $2M
San Diego-based drug developer Meritage Pharma raised $2 million in a round of equity-based financing planned to total $5.5 million, an SEC filing indicates. Meritage is out to develop a treatment for a little-known ailment called eosinophilic esophagitis, in which an allergic reaction causes a patient’s esophagus to swell, sometimes to the point where food becomes … Continue reading “Meritage Swallows $2M”
LinkedIn Files for $175 Million IPO, Reveals Financial and Membership Details
Nearly eight years after its founding, LinkedIn, the professional social networking site funded by Sequoia Capital, Greylock Partners, and Bessemer Venture Partners, today began the process of going public. The Mountain View, CA-based firm filed S-1 registration papers with the Securities and Exchange Commission, saying that it intends to raise up to $175 million in … Continue reading “LinkedIn Files for $175 Million IPO, Reveals Financial and Membership Details”
GE Loans XDx $12.5M
XDx, the Brisbane, CA-based molecular diagnostics company, said today that it has secured a $12.5 million loan from GE Capital, Healthcare Financial Services (technically it called the loan a “senior secured multi-draw term loan facility”). The company said the funds will give it enough runway to move forward with commercialization of its FDA-approved “AlloMap” test, … Continue reading “GE Loans XDx $12.5M”
Washington Startups See Spike in Investing Dollars in December
Washington startups must have been good this year, because they sure did nab some serious dollars come holiday time. The state’s tech and life sciences companies collected a total of $69.4 million across 17 equity-based financings, nearly triple November’s funding pot, according to data on venture, angel, and growth equity financing provided by CB Insights … Continue reading “Washington Startups See Spike in Investing Dollars in December”
Merck, Staring at a Biotech Future, Seeks to Get in the Game With New Protein Drugs, Biosimilars
Biotech drugs will soon dominate the pharmaceutical industry, according to analyst estimates of what are projected to be the world’s top 10 selling therapies in 2014. Eight of these brands on this list are products of genetic engineering, while only two are traditional oral pills made through chemical synthesis. One other thing jumps out. Not … Continue reading “Merck, Staring at a Biotech Future, Seeks to Get in the Game With New Protein Drugs, Biosimilars”
Personalized Medicine Regulation Needs More Than Band-Aids
Last week, New York State assemblyman J. Gary Pretlow introduced the descriptively named “act to amend the insurance law, in relation to requiring coverage for genetic testing in accident and health insurance polices.” While not accompanied by a press release, or widely covered by media outlets, the bill merits close attention. While the substance of … Continue reading “Personalized Medicine Regulation Needs More Than Band-Aids”
Clinical Data Stock Soars on FDA Approval, Amgen Buys BioVex, Stromedix Raises $2M, & More Boston-Area Life Sciences News
We saw news of regulatory approvals, acquisitions, financings, and an even a new venture group surrounding Boston’s life sciences firms this week. —A European Medicines Agency committee advised against approval of fampridine (Fampyra), Weston, MA-based Biogen Idec’s drug for improving multiple sclerosis patients’ ability to walk. Biogen (NASDAQ: [[ticker:BIIB]] says it will appeal the opinion. … Continue reading “Clinical Data Stock Soars on FDA Approval, Amgen Buys BioVex, Stromedix Raises $2M, & More Boston-Area Life Sciences News”
Rib-X Pharmaceuticals Garners $5,500,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=2cfa96c8-dbb3-4f8b-b4d4-b9cfcd36445f&Preview=1 Date 1/28/2011 Company Name Rib-X Pharmaceuticals Mailing Address 300 George Street New Haven, CT 06511 Company Description Rib-X Pharmaceuticals is a product-driven small molecule drug discovery and development company focused on the structure-based design of new classes of antibiotics. The company’s underlying drug discovery engine capitalizes on its proprietary high-resolution crystal … Continue reading “Rib-X Pharmaceuticals Garners $5,500,000 New Round”
PhysioSonics Obtains Series B Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=db4b1a74-31bf-4786-967a-84a5addc3171&Preview=1 Date 1/28/2011 Company Name PhysioSonics Mailing Address 14450 NE 29th Pl Bellevue, WA 98100 Company Description PhysioSonics, formerly known as Allez PhysiOnix, is a privately held company, founded in 2000 with technology developed at the University of Washington. The company has developed and patented a number of new technologies including an … Continue reading “PhysioSonics Obtains Series B Funding”
Lockerz Acquires Plixi for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8ac0392f-1105-4860-8592-d26183b456cf&Preview=1 Date 1/28/2011 Company Name Plixi Mailing Address 1912 Circle Park Lane Encinitas, CA 92024 Company Description Plixi is a real-time photo sharing platform for the social web. This free service allows you to share photos on Twitter, Facebook, and more. The service focuses on creating the best possible user-experience among the … Continue reading “Lockerz Acquires Plixi for Undisclosed Sum”
XDx Receives $12,500,000 New Financing Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c3205c99-c086-452e-aca0-27eec6da5f0a&Preview=1 Date 1/28/2011 Company Name XDx Mailing Address 3260 Bayshore Blvd Brisbane, CA 94005 Company Description XDx is a molecular diagnostics company, XDx is one of the first companies to develop and commercialize practical applications built on insights from the Human Genome Project. Website http://www.xdx.com Transaction Type Debt Transaction Amount $12,500,000 Transaction … Continue reading “XDx Receives $12,500,000 New Financing Round”
Meritage Pharma Obtains $2,000,001 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=624413b5-c22f-4bfa-a08f-604707783ddb&Preview=1 Date 1/28/2011 Company Name Meritage Pharma Mailing Address 12481 High Bluff Drive San Diego, CA 92130 Company Description Meritage Pharma is committed to the development of prescription products based on proven safe and effective molecules to meet the unmet needs of patients and their caregivers. Meritage Pharma’s initial product candidate is … Continue reading “Meritage Pharma Obtains $2,000,001 New Financing”
Oversee Acquires ShopWiki for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=966460dc-ac66-4285-82cf-f06cf28d0351&Preview=1 Date 1/28/2011 Company Name ShopWiki Mailing Address 17 West 18th Sreet 8th Floor New York, NY 10011 Company Description ShopWiki is the complete shopping search engine, combining breakthrough search and Web crawling technologies with consumer-driven wiki technology to help shoppers make the most informed buying decisions. Website http://www.shopwiki.com Transaction Type M&A … Continue reading “Oversee Acquires ShopWiki for Undisclosed Sum”
UsingMiles Secures $2,703,850 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5929554d-868e-464f-a56b-c87537a0f538&Preview=1 Date 1/28/2011 Company Name UsingMiles Mailing Address 6400 South Fiddlers Green Cir. Greenwood Village, CO 80111 Company Description We’re the only website that allows you to manage, search, and book travel using your frequent flyer miles and hotel points for free. Website http://www.usingmiles.com Transaction Type Venture Equity Transaction Amount $2,703,850 Transaction … Continue reading “UsingMiles Secures $2,703,850 New Funding Round”
HelioVolt Receives $8,520,941 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d1b849f7-b41e-48cc-ba05-88eb09fbc5b3&Preview=1 Date 1/28/2011 Company Name HelioVolt Mailing Address 6301-8 E. Stassney Lane Austin, TX 78744-3055 Company Description HelioVolt has pioneered a method of manufacturing high-performing solar technology and applying it as a coating directly onto conventional building materials. Website http://www.heliovolt.net Transaction Type Debt Transaction Amount $8,520,941 Transaction Round Undisclosed Proceeds Purposes Proceeds … Continue reading “HelioVolt Receives $8,520,941 New Funding”
Establishing a ‘TC/IP’ for Human Biology: Sage Bionetworks Data Summit
“Why Can’t We Just Share all Genomics and Clinical Data?” is the organizing idea behind a data summit hosted by Sage Bionetworks on Jan. 31. The event, titled “Establishing a TC/IP for Human Biology,” on how to make genomic and clinical data more interoperable, will be held on campus at the Fred Hutchinson Cancer Research … Continue reading “Establishing a ‘TC/IP’ for Human Biology: Sage Bionetworks Data Summit”
Arena Pharmaceuticals Axes One-Fourth of Workforce As it Hangs On With Obesity Drug
Arena Pharmaceuticals (NASDAQ: [[ticker:ARNA]]) is making a big round of job cuts today to conserve cash as it keeps pushing to satisfy questions U.S. regulators have about its lead obesity drug in development. The San Diego-based developer of the obesity treatment lorcaserin said today it has eliminated 66 jobs, or about 25 percent of its … Continue reading “Arena Pharmaceuticals Axes One-Fourth of Workforce As it Hangs On With Obesity Drug”
Heartland, Vertex Moving to Boston’s Waterfront
Cambridge, MA-based Heartland Robotics, the manufacturing robotics company founded by Rod Brooks, is moving into a larger office space in Boston’s Fort Point district next week, according to a report in Mass High Tech. The news comes on the heels of a Boston Globe report that says Vertex Pharmaceuticals (NASDAQ: [[ticker:VRTX]]), also based in Cambridge, … Continue reading “Heartland, Vertex Moving to Boston’s Waterfront”
Shrinkage—Expanded Upon….
Poor investment returns have had a similar effect to cold water – the VC industry is shrinking. As a follow-up to comments I posted this past weekend, I wanted to look deeper into recent fundraising data and see what other implications one might draw. Since 1980 the VC industry has raised $495 billion across 4,333 … Continue reading “Shrinkage—Expanded Upon….”
ISPE Tour at CMC Icos Biologics
The International Society for Pharmaceutical Engineering’s Northwest chapter is organizing a tour of the CMC Icos Biologics facility in Bothell, WA on February 17. For more information on how to register, contact Katie at [email protected].
Inside the Genomic Revolution: UW’s Stan Fields at Science on Tap
University of Washington genome sciences professor Stan Fields will be the featured speaker at Science on Tap in Ravenna on Jan. 31st. For more information, click here.
BrightEdge Going Global
BrightEdge, a San Mateo, CA, company that introduced its Web-based search engine optimization platform for businesses last summer, said today that it has brought on Ming Lei, chief architect at leading Chinese search engine Baidu, as a strategic advisor. Lei is expected to help the company expand its platform so that customers can increase incoming … Continue reading “BrightEdge Going Global”
In Utah, Developing the Science of Entrepreneurship
Utah may be known for many things, but who would have thought that Utah, and particularly Brigham Young University (BYU), would be participating in the transformation of entrepreneurship? I spent last weekend in Utah at BYU as a guest of Professor Nathan Furr, (a former Ph.D. student of our MS&E department at Stanford,) where they … Continue reading “In Utah, Developing the Science of Entrepreneurship”
A Done Deal: Ligand Diversifies its Drug Revenue With CyDex Acquisition
Investors showed little response this morning after San Diego’s Ligand Pharmaceuticals (NASDAQ: [[ticker:LGND]]) said yesterday it had acquired CyDex Pharmaceuticals for more than $36 million in mostly borrowed cash. After gaining a few cents a share, Ligand’s stock reversed course, and was down 9 cents a share at mid-day, to $8.67 a share in normal … Continue reading “A Done Deal: Ligand Diversifies its Drug Revenue With CyDex Acquisition”
The Spirit of Entrepreneurship Lives in Silicon Valley—A Report from The MIT Sloan Tech Trek
The three asses of entrepreneurship—A smart-ass team with a kick-ass product in a big-ass market: Never before has entrepreneurship been so succinctly captured as in this line coined by Jeff Clavier of Softtech VC. I met Jeff during the Silicon Valley “tech trek” organized by the MIT Sloan School of Management earlier this month. As … Continue reading “The Spirit of Entrepreneurship Lives in Silicon Valley—A Report from The MIT Sloan Tech Trek”
Venture Café Finds Permanent Space Amid Comings and Goings in Kendall Square
‘Tis the season for moving in and moving out for the startup community in Kendall Square. This morning, we heard some news from Tim Rowe, the CEO and co-founder of the Cambridge Innovation Center (CIC), about a new permanent location for the Venture Café, a popular gathering place for the innovation community. Venture Café “alpha” … Continue reading “Venture Café Finds Permanent Space Amid Comings and Goings in Kendall Square”
Novartis Acquires Genoptix, Elcelyx Raises $6M, Pfenex Gets Subcontract to Work on Malaria Treatment, & More San Diego Life Sciences News
Much of the life sciences news out of San Diego over the past week concerned new technologies and treatments for diabetes and obesity. We’ve got it covered. —Switzerland’s Novartis AG agreed to pay $470 million to buy Genoptix (NASDAQ: [[ticker:GXDX]]), a Carlsbad, CA-based company that centralized the business of providing specialized diagnostic services for cancers … Continue reading “Novartis Acquires Genoptix, Elcelyx Raises $6M, Pfenex Gets Subcontract to Work on Malaria Treatment, & More San Diego Life Sciences News”